Cargando…
Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial
Aim: High prevalence of metabolic disorders causes higher risk of cardiovascular diseases after kidney transplantation (KT), which remains the main burden impairing short-term and long-term survival. This open-label, prospective, randomized, 3-arm, controlled trial will evaluate the safety, tolerabi...
Autores principales: | Yin, Saifu, Ma, Ming, Huang, Zhongli, Fan, Yu, Wang, Xianding, Song, Turun, Lin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733302/ https://www.ncbi.nlm.nih.gov/pubmed/35004776 http://dx.doi.org/10.3389/fmed.2021.800872 |
Ejemplares similares
-
Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation
por: Yin, Saifu, et al.
Publicado: (2022) -
Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg− recipients: protocol for a multicentre, prospective, observational study
por: Wang, Xianding, et al.
Publicado: (2021) -
Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation
por: Yin, Saifu, et al.
Publicado: (2021) -
Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation
por: Zhang, Fan, et al.
Publicado: (2021) -
Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation
por: Song, Turun, et al.
Publicado: (2019)